Your browser doesn't support javascript.
loading
Circulating amino acid levels and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition and UK Biobank cohorts.
Rothwell, Joseph A; Besevic, Jelena; Dimou, Niki; Breeur, Marie; Murphy, Neil; Jenab, Mazda; Wedekind, Roland; Viallon, Vivian; Ferrari, Pietro; Achaintre, David; Gicquiau, Audrey; Rinaldi, Sabina; Scalbert, Augustin; Huybrechts, Inge; Prehn, Cornelia; Adamski, Jerzy; Cross, Amanda J; Keun, Hector; Chadeau-Hyam, Marc; Boutron-Ruault, Marie-Christine; Overvad, Kim; Dahm, Christina C; Nøst, Therese Haugdahl; Sandanger, Torkjel M; Skeie, Guri; Zamora-Ros, Raul; Tsilidis, Kostas K; Eichelmann, Fabian; Schulze, Matthias B; van Guelpen, Bethany; Vidman, Linda; Sánchez, Maria-José; Amiano, Pilar; Ardanaz, Eva; Smith-Byrne, Karl; Travis, Ruth; Katzke, Verena; Kaaks, Rudolf; Derksen, Jeroen W G; Colorado-Yohar, Sandra; Tumino, Rosario; Bueno-de-Mesquita, Bas; Vineis, Paolo; Palli, Domenico; Pasanisi, Fabrizio; Eriksen, Anne Kirstine; Tjønneland, Anne; Severi, Gianluca; Gunter, Marc J.
Afiliação
  • Rothwell JA; Centre for Epidemiology and Population Health (Inserm U1018), Exposome and Heredity team, Faculté de Médecine, Université Paris-Saclay, UVSQ, Gustave Roussy, F-94805, Villejuif, France. joseph.rothwell@inserm.fr.
  • Besevic J; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Dimou N; International Agency for Research on Cancer (IARC), 150 cours Albert Thomas, 69008, Lyon, France.
  • Breeur M; International Agency for Research on Cancer (IARC), 150 cours Albert Thomas, 69008, Lyon, France.
  • Murphy N; International Agency for Research on Cancer (IARC), 150 cours Albert Thomas, 69008, Lyon, France.
  • Jenab M; International Agency for Research on Cancer (IARC), 150 cours Albert Thomas, 69008, Lyon, France.
  • Wedekind R; International Agency for Research on Cancer (IARC), 150 cours Albert Thomas, 69008, Lyon, France.
  • Viallon V; International Agency for Research on Cancer (IARC), 150 cours Albert Thomas, 69008, Lyon, France.
  • Ferrari P; International Agency for Research on Cancer (IARC), 150 cours Albert Thomas, 69008, Lyon, France.
  • Achaintre D; International Agency for Research on Cancer (IARC), 150 cours Albert Thomas, 69008, Lyon, France.
  • Gicquiau A; International Agency for Research on Cancer (IARC), 150 cours Albert Thomas, 69008, Lyon, France.
  • Rinaldi S; International Agency for Research on Cancer (IARC), 150 cours Albert Thomas, 69008, Lyon, France.
  • Scalbert A; International Agency for Research on Cancer (IARC), 150 cours Albert Thomas, 69008, Lyon, France.
  • Huybrechts I; International Agency for Research on Cancer (IARC), 150 cours Albert Thomas, 69008, Lyon, France.
  • Prehn C; Metabolomics and Proteomics Core, Helmholtz Zentrum München, 85764, Neuherberg, Germany.
  • Adamski J; Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, 8 Medical Drive, Singapore, 117597, Singapore.
  • Cross AJ; Institute of Experimental Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health, Ingolstädter Landstraße 1, 85764, Neuherberg, Germany.
  • Keun H; Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000, Ljubljana, Slovenia.
  • Chadeau-Hyam M; School of Public Health, Imperial College London, London, UK.
  • Boutron-Ruault MC; Department of Surgery & Cancer, Imperial College London, London, UK.
  • Overvad K; School of Public Health, Imperial College London, London, UK.
  • Dahm CC; Centre for Epidemiology and Population Health (Inserm U1018), Exposome and Heredity team, Faculté de Médecine, Université Paris-Saclay, UVSQ, Gustave Roussy, F-94805, Villejuif, France.
  • Nøst TH; Department of Public Health, Aarhus University, Bartholins Allé 2, DK-8000, Aarhus, Denmark.
  • Sandanger TM; Department of Public Health, Aarhus University, Bartholins Allé 2, DK-8000, Aarhus, Denmark.
  • Skeie G; Faculty of Health Sciences, Department of Community Medicine, UiT the Arctic University of Norway, N-9037, Tromsø, Norway.
  • Zamora-Ros R; Faculty of Health Sciences, Department of Community Medicine, UiT the Arctic University of Norway, N-9037, Tromsø, Norway.
  • Tsilidis KK; Faculty of Health Sciences, Department of Community Medicine, UiT the Arctic University of Norway, N-9037, Tromsø, Norway.
  • Eichelmann F; Unit of Nutrition and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
  • Schulze MB; School of Public Health, Imperial College London, London, UK.
  • van Guelpen B; Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece.
  • Vidman L; German Center for Diabetes Research (DZD), Munchen-Neuherberg, Germany.
  • Sánchez MJ; Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
  • Amiano P; Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
  • Ardanaz E; Institute of Nutritional Science, University of Potsdam, Potsdam, Germany.
  • Smith-Byrne K; Department of Radiation Sciences, Oncology Unit, Umeå University, Umeå, Sweden.
  • Travis R; Wallenberg Centre for Molecular Medicine, Umeå University, Umeå, Sweden.
  • Katzke V; Department of Radiation Sciences, Oncology Unit, Umeå University, Umeå, Sweden.
  • Kaaks R; Escuela Andaluza de Salud Pública (EASP), 18011, Granada, Spain.
  • Derksen JWG; Instituto de Investigación Biosanitaria ibs. GRANADA, 18012, Granada, Spain.
  • Colorado-Yohar S; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 28029, Madrid, Spain.
  • Tumino R; Department of Preventive Medicine and Public Health, University of Granada, 18071, Granada, Spain.
  • Bueno-de-Mesquita B; Ministry of Health of the Basque Government, Sub Directorate for Public Health and Addictions of Gipuzkoa, San Sebastián, Spain.
  • Vineis P; Biodonostia Health Research Institute, Epidemiology of Chronic and Communicable Diseases Group, San Sebastián, Spain.
  • Palli D; Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.
  • Pasanisi F; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 28029, Madrid, Spain.
  • Eriksen AK; Navarra Public Health Institute, Leyre 15, 31003, Pamplona, Spain.
  • Tjønneland A; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.
  • Severi G; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Gunter MJ; International Agency for Research on Cancer (IARC), 150 cours Albert Thomas, 69008, Lyon, France.
BMC Med ; 21(1): 80, 2023 02 28.
Article em En | MEDLINE | ID: mdl-36855092
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Aminoácidos Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Aminoácidos Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2023 Tipo de documento: Article